Despite this evidence, well‐designed metabolic studies investigating Nur77 and NOR1 gene and protein expression in skeletal muscle have failed to demonstrate effect in the context of obesity, insulin resistance and T2DM, or following chronic adaptations to therapeutic lifestyle interventions. The gene discussed is NR4A1; the disease is obesity disorder.